Literature DB >> 9371664

Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation.

Y Naka1, H C Marsh, S M Scesney, M C Oz, D J Pinsky.   

Abstract

Although agents that inhibit complement activation may be beneficial in discordant xenotransplantation, it is not known whether local complement activation occurs and is deleterious after isogeneic lung transplantation. Lungs were harvested from Lewis rats subjected to 4 degrees C 6-hr preservation followed by transplantation into strain-, gender-, and weight-matched recipients. Transplanted lungs demonstrated increased immunostaining for C5b-9 compared with nontransplanted controls, confirming local complement activation in this isograft model. To investigate the physiologic relevance of complement activation in the transplanted lung, the native pulmonary artery was ligated after transplantation, and pulmonary vascular resistance (mmHg/ml/min), arterial oxygenation (mmHg), graft neutrophil infiltration (myeloperoxidase activity, deltaAbs 460 nm/min), and recipient survival were measured at 30 min. Animals received either saline (control; n=22) or soluble complement receptor type-1 (sCR1, 15 mg/kg; n=19) 2 min before reperfusion. Animals treated with sCR1 showed a marked reduction in serum complement hemolytic activity (CH50; 90% lower than that of control animals, P<0.001). Compared with controls, sCR1-treated animals showed reduced pulmonary vascular resistance (2.9+/-1.1 vs. 8.5+/-1.5 mmHg/ml/min, P<0.05), improved arterial oxygenation (194+/-34 vs. 91+/-17 mmHg, P<0.05), decreased neutrophil infiltration (35% decrease, P<0.005), and improved recipient survival (74% vs. 23%, P<0.005). In parallel with the reduction in complement hemolytic activity in sCR1-treated animals, immunohistology of the transplanted lung revealed decreased C5b-9 deposition compared with controls. Taken together, these data indicate that complement activation occurs after lung preservation and transplantation in an isograft model, and that inhibiting complement activation improves outcome after transplantation.

Entities:  

Mesh:

Year:  1997        PMID: 9371664     DOI: 10.1097/00007890-199711150-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

Review 2.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

3.  Experimental orthotopic lung transplantation model in rats with cold storage.

Authors:  Ryujiro Sugimoto; Atsunori Nakao; Itaru Nagahiro; Junichi Kohmoto; Seiichiro Sugimoto; Mikio Okazaki; Masaomi Yamane; Hidetoshi Inokawa; Takahiro Oto; Kazunori Tahara; Jianghua Zhan; Yoshifumi Sano; Kenneth R McCurry
Journal:  Surg Today       Date:  2009       Impact factor: 2.549

4.  The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.

Authors:  A A Abbas; J M Diamond; C Chehoud; B Chang; J J Kotzin; J C Young; I Imai; A R Haas; E Cantu; D J Lederer; K C Meyer; R K Milewski; K M Olthoff; A Shaked; J D Christie; F D Bushman; R G Collman
Journal:  Am J Transplant       Date:  2016-11-04       Impact factor: 8.086

5.  Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.

Authors:  Rupal J Shah; Amir M Emtiazjoo; Joshua M Diamond; Patricia A Smith; David W Roe; Keith M Wille; Jonathan B Orens; Lorraine B Ware; Ann Weinacker; Vibha N Lama; Sangeeta M Bhorade; Scott M Palmer; Maria Crespo; David J Lederer; Edward Cantu; George J Eckert; Jason D Christie; David S Wilkes
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

Review 6.  Complement system in lung disease.

Authors:  Pankita H Pandya; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2014-10       Impact factor: 6.914

Review 7.  Clinical relevance of lung-restricted antibodies in lung transplantation.

Authors:  Mahzad Akbarpour; Qiang Wu; Xianpeng Liu; Haiying Sun; Emilia Lecuona; Rade Tomic; Sangeeta Bhorade; Thalachallour Mohanakumar; Ankit Bharat
Journal:  Hum Immunol       Date:  2019-05-08       Impact factor: 2.850

Review 8.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.